Bayer Q2 EPS $0.33 Beats $0.31 Estimate, Sales $12.04B Miss $12.56B Estimate
Portfolio Pulse from Benzinga Newsdesk
Bayer (OTC:BAYRY) reported Q2 earnings of $0.33 per share, beating the analyst consensus estimate of $0.31 by 7.1%. However, this is a 34.9% decrease from the same period last year. The company's quarterly sales of $12.04 billion missed the analyst consensus estimate of $12.56 billion by 4.14%, marking an 11.87% decrease from the same period last year.
August 08, 2023 | 6:52 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bayer's Q2 earnings beat estimates but are down 34.9% YoY. Sales missed estimates and are down 11.87% YoY.
Bayer's earnings beat estimates, which is positive. However, the YoY decrease in both earnings and sales, as well as the missed sales estimates, are negative indicators that could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100